Results 191 to 200 of about 3,371,263 (384)
Background Ecological momentary assessment (EMA) can reveal naturalistic within‐person changes in symptoms and behaviors, essential for examining psychotherapy's effectiveness. However, no prior study has leveraged EMA to assess real‐time, naturalistic changes of clinical symptoms during psychotherapy in youth with clinically impairing irritability ...
Reut Naim +6 more
wiley +1 more source
BACKGROUND AND OBJECTIVE: Atypical antipsychotic drugs are first line treatment for psychotic disorders and well tolerated by the patients because of less extra pyramidal side effects and better efficacies. But there are different reports about metabolic
A Masoudzadeh +3 more
doaj
These surveys reveal inconsistent electronic patient record (EPR) systems and poor documentation standards for non‐drug allergies, leading to high incident rates and misclassification. Standardised documentation, improved training and user‐friendly EPR platforms are urgently needed to enhance patient safety and reduce allergy‐related incidents across ...
Melvin Lee Qiyu +2 more
wiley +1 more source
Abstract Objective This study provides real‐world evidence on the comparative effectiveness of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) regarding the risk of incident dementia in adults with type 2 diabetes mellitus (T2DM).
Filippos Anagnostakis +4 more
wiley +1 more source
Abstract Aim Type 2 diabetes (T2D) is associated with increased dementia risk, but comparative data across newer glucose‐lowering therapies remain limited. We examined whether the initiation of GLP‐1 receptor agonists (GLP‐1 RAs) was associated with incident dementia compared with DPP4 inhibitors (DPP4is) and SGLT2 inhibitors (SGLT2is) in older adults ...
Ting Zhou +9 more
wiley +1 more source
Risk Evaluation for Antipsychotic Agents Used in Elderly Inpatients (REPAIR). [PDF]
Yu F, Rafizadeh R, Mabasa VH, Kang N.
europepmc +1 more source

